It has been suggested that a sustained virologic response (SVR) can be achieved in patients infected with hepatitis C virus (HCV) of genotype 2 or 3 with a shorter duration of pegylated interferon ...
GENT, Belgium--(BUSINESS WIRE)--Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc.
Hepatitis C is one of the most common viral infections in the United States. Without treatment, hepatitis C can lead to severe health issues. Epclusa was approved to treat chronic hepatitis C by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results